• Mashup Score: 1

    In patients with stable symptoms and a ZCS, obstructive CAD is rare, and prognosis over the long-term is excellent, regardless of whether non-calcified atheroma is identified. A ZCS could reliably be used as a ‘gatekeeper’ in this patient cohort, obviating the need for further more expensive tests.

    Tweet Tweets with this article
    • @Hragy @DavidLBrownMD @drpablocorral @rauldsf_santos @ethanjweiss @DrScottMurray @DBelardoMD @ProfKausikRay @lipiddoc @AnnMarieNavar @reed_mszar https://t.co/tUKYMKuBo1 3914 pts with suspected stable CHD referred for CCTA 52% with CAC Zero NPV for #PowerOfZero excluding stenosis 99.5% Upto 13-year follow-up period ZERO patients with CAC=0 died of a "coronary event"👇 "questioning" need for testing in this situation https://t.co/bopnY9sMOG

  • Mashup Score: 0

    Weekly news , posts and updates for Lipidology & Cardiovascular Disease Prevention by Dr. James Underberg

    Tweet Tweets with this article
    • The latest LipidDoc's Daily is out !! https://t.co/nW99W2wqkn Thanks to @ErinMichos @Drlipid @DrMarthaGulati #tirzepatide #powerofzero